As anticipated, Evaxion has received a delisting determinationThe determination has been appealed by Evaxion requesting a hearing on the matter and seeking another 180-day extension to comply with Nas ...
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...
Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...
Novavax cut its annual revenue forecast on Tuesday, citing lower-than-expected sales of its COVID-19 vaccine, ahead of ...
The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
Jurors in U.S. District Court in Detroit punished Blue Cross Blue Shield of Michigan for terminating an employee for refusing ...
Novavax had been hoping to find a sizable sales opportunity by advancing a protein-based alternative to the messenger RNA ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback